Literature DB >> 1773799

Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.

S H Yuspa1, A Kilkenny, C Cheng, D Roop, H Hennings, F Kruszewski, E Lee, J Strickland, D A Greenhalgh.   

Abstract

The induction of cancer on mouse skin by initiation-promotion protocols occurs through stages in which a benign squamous papilloma is an obligate precursor of squamous cell carcinoma. Activation of the Ha-ras gene is sufficient to produce the papilloma phenotype, while additional genetic changes are required for malignant conversion. The introduction of Ha-ras into normal keratinocytes suppresses the expression of differentiation markers, keratin K1 and K10, and loricrin (a cornified envelope precursor) and, to a lesser extent, filaggrin, at the level of transcription. However, cells initiated by Ha-ras express a nonepidermal keratin, K8. The transcription of K8 in these cells is sensitive to the level of medium Ca2+, being abundant in 0.5 mM Ca2+ and not detected in 0.05 mM Ca2+. Epidermal differentiation is regulated by signalling, which involves changes in phosphatidylinositol turnover and intracellular Ca2+. Cells initiated by Ha-ras do not differ from normal keratinocytes in their intracellular Ca2+ response patterns, at least in response to changes in extracellular Ca2+ and serum factors. However, c-Ha-ra keratinocytes have a high basal level of phosphatidylinositol (PI) turnover, which is additive with several other inducers of this pathway, including Ca2+ and aluminum fluoride. Additional studies suggest that high turnover of the PI pathway is incompatible with differentiation-specific gene expression in keratinocytes. We suggest this negative relationship is mediated through elevated diacylglycerol production and chronic down-modulation of protein kinase C. Protein kinase C is known to be essential for expression of differentiation-related genes in keratinocytes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1773799      PMCID: PMC1568044          DOI: 10.1289/ehp.91933

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  57 in total

Review 1.  Proteinases and their inhibitors in cells and tissues.

Authors:  G Rappay
Journal:  Prog Histochem Cytochem       Date:  1989

2.  Hidden self-association of proteins.

Authors:  N Muramatsu; A P Minton
Journal:  J Mol Recognit       Date:  1989-04       Impact factor: 2.137

3.  Rapid stimulation of diacylglycerol production in Xenopus oocytes by microinjection of H-ras p21.

Authors:  J C Lacal; P de la Peña; J Moscat; P Garcia-Barreno; P S Anderson; S A Aaronson
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

4.  Analysis of the rasH oncogene and its p21 product in chemically induced skin tumors and tumor-derived cell lines.

Authors:  J R Harper; S H Reynolds; D A Greenhalgh; J E Strickland; J C Lacal; S H Yuspa
Journal:  Carcinogenesis       Date:  1987-12       Impact factor: 4.944

Review 5.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

6.  Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene.

Authors:  D A Greenhalgh; S H Yuspa
Journal:  Mol Carcinog       Date:  1988       Impact factor: 4.784

7.  Involvement of functional protein kinase C in the mitogenic response to the H-ras oncogene product.

Authors:  J C Lacal; T P Fleming; B S Warren; P M Blumberg; S A Aaronson
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

8.  ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites.

Authors:  L F Fleischman; S B Chahwala; L Cantley
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

9.  Regression kinetics of mouse skin papillomas.

Authors:  F J Burns; M Vanderlaan; A Sivak; R E Albert
Journal:  Cancer Res       Date:  1976-04       Impact factor: 12.701

10.  The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors.

Authors:  L M Matrisian; G T Bowden; P Krieg; G Fürstenberger; J P Briand; P Leroy; R Breathnach
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  6 in total

Review 1.  Stage-specific gene expression during hepatocarcinogenesis in the rat.

Authors:  H C Pitot
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression.

Authors:  S Zhu; H S Oh; M Shim; E Sterneck; P F Johnson; R C Smart
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

3.  Expression of the carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins.

Authors:  F Bernerd; T Magnaldo; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

4.  Antioxidant enzymes are elevated in dimethylbenz[a]anthracene-induced neoplastic murine keratinocytes containing an active rasHa oncogene.

Authors:  K Lehtola; L Laurikainen; L Leino; M Ahotupa; K Punnonen
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin.

Authors:  A Lymboussaki; A Kaipainen; E Hatva; I Västrik; L Jeskanen; M Jalkanen; S Werner; F Stenbäck; R Alitalo
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

Review 6.  The human keratins: biology and pathology.

Authors:  Roland Moll; Markus Divo; Lutz Langbein
Journal:  Histochem Cell Biol       Date:  2008-05-07       Impact factor: 4.304

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.